Isolation and characterization of proteoglycan derived from human placentaand its biological activities

Citation
Kb. Lee et al., Isolation and characterization of proteoglycan derived from human placentaand its biological activities, ARCH PH RES, 23(2), 2000, pp. 182-186
Citations number
9
Categorie Soggetti
Pharmacology & Toxicology
Journal title
ARCHIVES OF PHARMACAL RESEARCH
ISSN journal
02536269 → ACNP
Volume
23
Issue
2
Year of publication
2000
Pages
182 - 186
Database
ISI
SICI code
0253-6269(200004)23:2<182:IACOPD>2.0.ZU;2-9
Abstract
Chondroitin sulfates proteoglycans were isolated from human placenta. For t he identification of enzymatic digestion products of isolated proteoglycan, strong anion exchange-high was pe;formed. By the action of chondroitin per formance liquid chromatography (SAX-HPLC) ABC and chondroitin B lyase, thre e unsaturated disaccharides 2-acetamide-2-deoxy-3-O-(beta-D-gluco-4-enepyra nosyluronic acid)-D-galactose (Delta Di-OS), 2-acetamide-2-deoxy-3-O-(beta- D-gluco-4-enepyranosyluronic acid)-6-O-sulfo-D-galactose (Delta Di-6S) and 2-acetamide-2-deoxy-3-O-(beta-D-gluco-4-enepyranoxyluronic acid)-4-O-sulfo- D-galactose (Delta Di-4S) were produced from the human placenta proteoglyca n. The anticoagulant activity of chondroitin sulfate proteoglycan was evalu ated by activated partial thromboplastin time (aPTT) assay and thrombin tim e (TT) assay. The dotting times of aPTT and TT were increased from 72 to 14 4 sec and 19 to 27 sec, respectively The immune-modulating activity of chon droitin sulfate proteoglycan was examined by cell proliferation assay and t hese results suggest that it may play a role in suppression of the function of immune-related cells.